French artificial heartmaker Carmat announced on Tuesday that it had carried out the first implant of its Aeson artificial heart in a woman.
The company said the procedure had been performed at the UofL Health - Jewish Hospital by University of Louisville physicians in the United States.
"This third implant in the US was a landmark event not only because it allowed us to finalise the enrollment of the first cohort of patients of the EFS (early feasibility study), but very importantly because it is the first time ever that our device has helped a woman suffering from heart failure," Carmat CEO Stephane Piat said in a statement.
Read More - www.gdnonline.com
